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Abstract
Background: Optimal management of patients with acute myocardial infarction (MI) due 
to critical stenosis of an unprotected left main coronary artery (ULMCA) is not established. 
However, data from observational studies and registries encourage to perform percutaneous 
coronary intervention (PCI) in high risk patients. We investigated gender-related discrepan-
cies, clinical course and prognosis in patients with acute MI and ULMCA as an infarct-related 
artery.
Methods: A total of 643 consecutive patients (184 [28.6%] females and 459 [71.4%] males) 
with acute MI due to critical ULMCA stenosis were selected from the population of 121,526 
patients hospitalized due to acute coronary syndromes between 2003 and 2006. The primary 
endpoints were in-hospital, 30-day, 6-month and 12-month mortality.
Results: Women were older than men with signifi cantly higher proportion of women older 
than 65 and with unfavorable risk profi le. The management in men and women was similar. 
There was no signifi cant gender-related differences in mortality in all follow-up periods. In 
multivariate analysis cardiogenic shock, pulmonary edema, ST elevation myocardial in-
farction (STEMI) and advanced age signifi cantly increased mortality, whereas successful PCI 
decreased mortality.
Conclusions: No signifi cant differences in clinical course, treatment and prognosis between 
men and women were noted. Mortality remained very high in both genders. The most unfa-
vorable prognostic factors were cardiogenic shock, pulmonary edema, STEMI and advanced 
age. Percutaneous coronary angioplasty is feasible and offers high success rate in this subset of 
patients. (Cardiol J 2013; 20, 2: 190–196)
Key words: acute coronary syndrome, left main coronary artery, mortality, 
therapeutic strategy, gender
Introduction
Since analysis of data from the CASS registry 
[1] critical stenosis of unprotected left main corona-
ry artery (ULMCA) has become a classic indication 
for coronary artery bypass grafting (CABG) in 
patients with stable angina pectoris. Effective and 
safe percutaneous coronary intervention (PCI) in 
ULMCA stenosis in stable patients is technically 
feasible, and long-term outcomes are highly sati-
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sfactory when drug-eluting stents are used [2, 3]. 
Patients at particularly high risk are those with 
acute myocardial infarction (MI) and ULMCA as an 
infarct-related artery. Optimal method for coronary 
revascularization in this population has not been 
assessed in randomized studies, however observa-
tional data and registries [4] encourage the use of 
percutaneous coronary intervention (PCI) in these 
highest-risk patients.
Because of the emphasis on studying gender-
-related differences in the prevalence and treat-
ment of cardiovascular disease, unfavorable clinical 
characteristics and suboptimal treatment of women 
with acute coronary syndromes have been docu-
mented in Poland [5, 6].
In the present study a unique attempt was 
made to assess clinical course, treatment and pro-
gnosis in men and women with MI due to critical 
stenosis of the left main coronary artery.
Methods
Of 121,526 patients with acute coronary syndro-
mes consecutively hospitalized between 2003 and 
2006 a group of 643 (1.9%) patients was identifi ed 
in whom coronary angiography confi rmed critical 
stenosis of ULMCA which was responsible for the 
development of ST-segment elevation myocardial 
infarction (STEMI) or non ST-segment elevation 
myocardial infarction (NSTEMI). The study group 
consisted of 184 (28.6%) women and 459 (71.4%) 
men. Data of hospitalized patients were obtained 
from the Polish Registry of Acute Coronary Syndro-
mes (PL-ACS). Data on post-discharge events were 
obtained from the National Health Fund and data 
regarding mortality from the Vital Statistics Offi ce. 
In order to identify gender-related differences in the 
course of ULMCA lesions and treatment women and 
men in the present study were compared with re-
spect to medical history, clinical symptoms, strategy 
of treatment, pharmacotherapy during in-hospital 
stay and medication prescribed at discharge. Stu-
dy end-points were defi ned as in-hospital death, 
mortality at 30 days, 6 and 12 months. Multivariate 
analysis included such factors as age, gender, pre-
sence of arterial hypertension, diabetes mellitus, 
smoking, obesity, previous MI, TIMI-3 fl ow prior 
to intervention, effective PCI (TIMI-3 fl ow post 
intervention), use of intraaortic counterpulsation 
and CABG.
Statistical analysis
Continuous variables, depending on the distri-
bution type, were presented as means ± standard 
deviation (SD) or median and interquartile range. 
The signifi cance of differences between the two 
means was tested using Student’s t-test or Mann-
-Whitney U-test. If the data were non-normally 
distributed the Kruskal-Wallis one-way analysis of 
variance by ranks or the Mann-Whitney U-test was 
performed. Homogeneity of variances was checked 
by means of the F test. Qualitative variables were 
tested using the χ2 test. One year mortality was 
analyzed using the Kaplan-Meier method, and the 
signifi cance of differences between the groups was 
tested using the log-rank test. Multivariate analysis 
of in-hospital and 12-month mortality was perfor-
med using multiple logistic regression. Results 
were presented as odds ratio (OR) and relative risk 
with 95% confi dence interval (95% CI). A p value 
≤ 0.05 was considered to be signifi cant.
Results
There were 643 consecutive patients with 
acute MI due to critical stenosis or acute occlusion 
of ULMCA, STEMI — 47.4%, NSTEMI — 52.6%. 
Women more frequently presented later than 2 h af-
ter symptom onset and were older than men. There 
was higher proportion of women over 65 and with 
arterial hypertension, diabetes and obesity. Cardiac 
arrest before hospitalization was more frequent in 
men (Table 1). There was a similar percentage of 
women in STEMI and NSTEMI group (28.9% vs. 
28.5%; p = 0.94). Isolated ULMCA disease was 
more frequent in STEMI group (30.6% vs. 16.0%; 
p < 0.0001) in contrast to NSTEMI group where mul -
tivessel disease was dominant (45.1% vs. 66.0%; 
p < 0.0001). In general, there were no signifi cant 
differences in the treatment strategy (Table 2) and 
pharmacotherapy between men and women except 
of more frequent use of diuretics (41.8% vs. 32.2%; 
p = 0.021) and insulin (22.3% vs. 14.2%; p = 0.012) 
in women. In women and men who underwent PCI 
there were different treatment options: plain old 
balloon angioplasty (10.7% vs. 10.5%; p = NS), bare 
metal stent (BMS, 27.0% vs. 73.0%; p = 0.0005) 
and drug-eluting stent (DES, 50% vs. 50%). There 
were no differences in mortality between genders 
in all follow-up periods (Table 3). However, when 
considering STEMI and NSTEMI subgroups the-
re was a clear difference in mortality in favor of 
NSTEMI both in in-hospital (27.2% vs. 10.4%; 
p < 0.0001) and in 12-month follow-up (38.4% 
vs. 24.6%; p < 0.0001). In patients treated with 
DES in-hospital (9.0% vs. 24.1%; p = 0.08) and 
12-month (20.0% vs. 33.2%; p = 0.05) there was 
a tendency towards lower mortality with borderline 
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signifi cance. Complication rate (reinfarction, stro-
ke, bleeding, target vessel revascularization) was 
relatively low and there were no signifi cant diffe-
rences between genders both in general population 
(Table 2) and in STEMI/NSTEMI subgroups (data 
not shown). In multivariable analysis cardiogenic 
shock, pulmonary edema, STEMI and advanced 
age signifi cantly increased in-hospital and 1-year 
mortality. Female sex did not infl uence mortality. 
Successful PCI assessed as post-procedural TIMI 
3 fl ow signifi cantly improved prognosis (Table 4).
Discussion
 Critical ULMCA stenosis is rare (5–7% of 
patients undergoing coronary angiography), it is 
however associated with serious prognosis. Eu-
ropean guidelines allow for PCI of the ULMCA in 
patients with single vessels disease and the lesion 
not extending to the bifurcation (Class IIa recom-
mendation), in more complex cases PCI is upgraded 
to a Class IIb recommendation, whereas in patients 
with multiple vessel disease or SYNTAX Score 
≥ 33 PCI of the ULMCA is contraindicated [7]. 
American guidelines say that PCI of the ULMCA 
can be considered in select patients (Class IIb 
recommendation) [8]. MI due to acute total occlu-
sion of ULMCA, if not leading almost immediately 
to death, usually is complicated by severe ventri-
cular arrhythmia and acute left ventricular failure 
as evidenced by pulmonary edema or shock with 
in-hospital and long-term mortality being very 
high. In stable patients CABG is the recommended 
modality offering good long-term outcomes. How-
ever, in patients with the ULMCA as the infarct-
-related artery optimal revascularization strategy 
is not obvious. Primary PCI in these patients is 
feasible and restores blood fl ow in a shorter time 
Table 1. Basic clinical characteristics.
Women, n = 184 
(28.6%)
Men, n = 459 
(71.4%)
P
Age 69.0±12.3 64.5±11.0 < 0.0001
Age ≥ 65 128 (69.6%) 235 (51.2%) < 0.0001
Arterial hypertension 136 (73.9%) 295 (64.3%) 0.019
Diabetes 59 (32.1%) 100 (21.8%) 0.0063
Hypercholesterolemia 93 (50.5%) 201 (43.8%) 0.12
Smoking 35 (19%) 179 (39%) < 0.0001
Obesity (BMI > 30 kg/m2) 50 (27.2%) 49 (10.7%) < 0.0001
Prior MI 40 (21.7%) 127 (27.7%) 0.12
Prior PCI 8 (4.3%) 18 (3.9%) 0.80
Prior CABG 11 (6%) 32 (7%) 0.65
Symptom onset  
— admission time
0–2 h 15 (8.2%) 64 (13.9%) 0.043
2–6 h 77 (41.8%) 162 (35.3%) 0.12
6–12 h 30 (16.3%) 64 (13.9%) 0.44
> 12 h 40 (21.7%) 110 (24%) 0.55
Killip class 4 30 (16.3%) 73 (15.9%) 0.90
3 14 (7.6%) 24 (5.2%) 0.25
1 and 2 140 (76.1%) 362 (78.9%) 0.44
CK-MB [U/L] Max. activity 57 (24-186) 62 (28-232) 0.25
EF
> 50% 38 (27.9%) 63 (20%) 0.063
30–50% 78 (57.4%) 188 (59.7%) 0.64
< 30% 20 (14.7%) 64 (20.3%) 0.16
Number of 
arteries diseased
LM only 46 (25.1%) 101 (22%) 0.39
LM + 1 33 (18%) 94 (20.5%) 0.48
LM + ≥ 2 102 (55.7%) 258 (56.2%) 0.91
BMI — body mass index; MI — myocardial infarction; PCI — percutaneous coronary intervention; CABG — coronary artery by-pass graf-
ting; CK-MB — creatine phosphokinase-myocardial isoenzyme; EF — ejection fraction; LM — left main
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than CABG. Short- and long-term outcomes and 
lower periprocedural risk of stroke, even with 
a higher rate of repeat revascularization within the 
treated vessel, offer a favorable alternative to sur-
gical treatment [9]. There is increasing evidence 
showing that outcomes after PCI of the ULMCA in 
stable patients does not differ from that after CABG 
with respect to the rate of post-procedural death 
or MI. For this reason there is growing interest in 
angioplasty procedures in highest risk patients in 
whom the fastest reperfusion (TIMI grade 3 fl ow) 
is closely associated with better prognosis [10, 11].
Because of the frequently described differen-
ces in the course of MI between men and women 
we analyzed a number of factors that might have 
an impact on the clinical manifestations of acute 
coronary syndromes caused by critical ULMCA 
stenosis in both sexes. Women were decidedly 
in the minority, they were older than men by 
4.5 years on average and they were diagnosed signifi  -
cantly more frequently with arterial hypertension, 
diabetes mellitus and obesity, and what’s perhaps 
most important time from the onset of pain to 
admission was longer than that for men. Most stu-
Table 2. Treatment strategy.
Women, n = 184 
(28.6%)
Men, n = 459 
(71.4%)
P
Conservative 55 (29.9%) 141 (30.7%) 0.84
Fibrinolysis 2 (1.1%) 12 (2.6%) 0.37
Invasive PCI 120 (65.2%) 279 (60.8%) 0.30
CABG 8 (4.3%) 29 (6.3%) 0.33
PCI + CABG 1 (0.5%) 7 (1.5%) 0.53
STEMI symptoms-to-balloon 
time
0–2 h 5 (6.8%) 17 (9.8%) 0.44
2–6 h 20 (27%) 58 (33.3%) 0.33
6–12 h 15 (20.3%) 22 (12.6%) 0.12
> 12 h 34 (45.9%) 77 (44.3%) 0.81
Stenting 108 (89.3%) 256 (89.5%) 0.94
IABP 25 (13.6%) 49 (10.7%) 0.30
GP IIb/IIIa antagonist 45 (24.5%) 112 (24.4%) 0.99
TIMI flow before PCI 0 45 (37.5%) 128 (45.1%) 0.16
1 26 (21.7%) 46 (16.2%) 0.19
2 18 (15.0%) 52 (18.3%) 0.42
3 31 (25.8%) 58 (20.4%) 0.23
Post-procedural TIMI flow 0 5 (4.1%) 16 (5.6%) 0.54
1 3 (2.5%) 13 (4.6%) 0.48
2 7 (5.8%) 22 (7.7%) 0.49
3 106 (87.6%) 234 (82.1%) 0.17
In-hospital complications STEMI 4 (2.2%) 7 (1.5%) 0.81
NSTEMI/UA 9 (4.9%) 21 (4.6%) 0.86
Stroke 0 (0%) 4 (0.9%) 0.47
Bleeding 6 (3.3%) 10 (2.2%) 0.61
Re-PCI 3 (1.6%) 6 (1.3%) 0.96
CABG — coronary artery by-pass grafting; PCI — percutaneous coronary intervention; IABP — intraaortic balloon pump; GP — glycopro-
tein; N/STEMI — non/ST-segment elevation myocardial infarction; UA — unstable angina, Re-PCI — target vessel revascularization
Table 3. Mortality.
Women, 
n = 184 
(28.6%)
Men, 
n = 459 
(71.4%)
P <
In-hospital 38 (20.7%) 80 (17.4%) 0.34
30-day 45 (24.5%) 100 (21.8%) 0.46
6-month 58 (31.5%) 127 (27.7%) 0.33
12-month 60 (32.6%) 140 (30.5%) 0.60
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dies comparing cardiovascular risk factors in men 
and women confi rm such risk distribution among 
patients admitted for MI [12]. It is noteworthy 
that the number of risk factors increases signifi -
cantly with age, however in those both below and 
over 65 years of age there are still more women 
with arterial hypertension, diabetes mellitus and 
obesity whereas more smokers are encountered 
among men. In a large database of patients with 
acute coronary syndromes admitted to hospitals in 
2001–2004 cardiovascular risk factors in men and 
women had similar rates of occurrence. Women 
made up about 30% of the study population, they 
were older than men by 6 years on average and had 
arterial hypertension (66.4% vs. 56.8%; p = 0.001) 
and diabetes (30.8% vs. 18.6%; p < 0.001), 
whereas there were more smokers among men 
(66.2% vs. 6.6%; p < 0.001) [13]. Although the 
statistics regarding patients with MI due to total 
occlusion of the left main coronary artery are 
limited, it seems that the distribution of major 
cardiovascular risk factors is similar to that in the 
population of MI patients in general. According 
to one of the few reports on patients undergoing 
angioplasty of the unprotected left main coronary 
artery stenosis women representing 27.8% of the 
study population were older and had been more 
frequently diagnosed with arterial hypertension and 
diabetes [14]. Signifi cantly less women were found 
to be admitted to hospital within 2 h after the onset 
of chest pain (8.2% vs. 13.9%; p = 0.043). Delay 
to treatment in MI frequently occurs in women. 
This fact is believed to be caused by differences 
in the clinical manifestations of acute coronary 
syndromes between men and women. One study 
evaluating the symptoms of acute MI in females 
demonstrated that chest pain was absent in almost 
50% of women, and shortness of breath (58%), 
weakness (55%) and fatigue (43%) were found 
instead [15]. Moreover, women’s low awareness 
of coronary risk not infrequently was the reason 
for ignoring the symptoms and not seeking me-
dical care. Therefore, women even with typical 
symptoms of MI were admitted to emergency 
departments later than men [16, 17].
Mortality after elective PCI with DES in low 
risk patients with ULMCA (good left ventricular 
ejection fraction, favorable anatomy of the left 
main bifurcation) is low [18, 19] as compared with 
very high (exceeding often 40%) mortality in MI 
due to ULMCA stenosis [20–23]. These reports 
are rare because of the short time elapsed from 
the introduction of PCI in these patients. In the 
present study in-hospital and annual mortality is 
high but relatively low as compared with other 
studies. Most investigators emphasize poorer pro-
Table 4. Multivariate analysis — in-hospital and 12-month mortality.
In-hospital
OR (95% CI)
P 12-month
RR (95% CI)
P
Age (per 10 years more) 1.40 (1.03–1.90) 0.030 1.35 (1.13–1.61) 0.0010
Female gender 1.24 (0.61–2.52) 0.55 1.03 (0.7–1.52) 0.88
Arterial hypertension 0.58 (0.29–1.15) 0.12 0.9 (0.62–1.31) 0.59
Diabetes 1.29 (0.60–2.77) 0.51 1.09 (0.72–1.65) 0.67
Smoking 0.61 (0.28–1.33) 0.22 0.64 (0.4–1.01) 0.053
Obesity 1.03 (0.40–2.65) 0.95 0.89 (0.51–1.53) 0.67
Prior MI 1.05 (0.47–2.37) 0.90 1.88 (1.22–2.9) 0.0041
Prior revascularization 0.71 (0.22–2.33) 0.57 0.54 (0.28–1.04) 0.066
Heart rate ≥ 100/min 0.76 (0.32–1.83) 0.54 1.05 (0.67–1.65) 0.83
Pulmonary edema 3.66 (1.16–11.59) 0.027 4.29 (2.4–7.66) < 0.0001
Cardiogenic shock 10.15 (4.94–20.87) < 0.0001 3.78 (2.45–5.84) < 0.0001
STEMI (vs. NSTEMI) 2.37 (1.14–4.91) 0.020 1.52 (1.01–2.27) 0.045
LM + 1 vessel 1.20 (0.48–2.98) 0.70 1.4 (0.83–2.37) 0.21
LM + 2 or more vessels 1.58 (0.71–3.52) 0.26 1.43 (0.91–2.27) 0.12
TIMI 3 flow before PCI 0.56 (0.22–1.46) 0.24 0.68 (0.41–1.15) 0.15
Post-procedural TIMI 3 flow 0.10 (0.05–0.23) < 0.0001 0.2 (0.13–0.3) < 0.0001
IABP 1.96 (0.87–4.41) 0.10 1.34 (0.88–2.04) 0.17
CABG 0.99 (0.09–10.97) 0.99 1.33 (0.45–3.94) 0.60
MI — myocardial infarction; PCI — percutaneous coronary intervention; CABG — coronary artery by-pass grafting; LM — left main; 
IABP — intraaortic balloon pump; N/STEMI — non/ST-segment elevation myocardial infarction
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gnosis in females, however these differences are 
increasingly frequently interpreted as a result of 
age and a larger number of risk factors. Analysis of 
a large database of patients admitted to hospital due 
to MI confi rmed higher in-hospital and early post 
discharge mortality among women and equalization 
of survival in both genders over longer follow-up. 
Investigators emphasize probable effects of the 
sex-specifi c clinical characteristics on these stati-
stics, and they also agree that reliable evaluation 
is diffi cult because of the nonhomogeneity of the 
studies. It is however suggested that higher early 
post MI mortality among women may be associated 
with less frequent use of an invasive management 
strategy and delayed admission to hospital [24].
Several investigations show better survival in 
women which is related to progress in reperfusion 
therapy. A population of patients admitted to hospital 
due to MI was analyzed in three series: group I: 
1981–1988 (fibrinolysis), group II: 1989–1995 
(balloon angioplasty), group III: 1996–2001 (PCI 
with stenting). Mortality over 3-year follow-up was 
higher in women in the fi rst two groups, whereas 
in group III there were no differences in mortality 
between men and women (12% vs. 10%; p = 0.66). 
The investigators emphasize that the number of 
men and women selected for reperfusion therapy 
was similar in all groups [25]. Analysis of patients 
undergoing angioplasty of the ULMCA generated 
similar results. Although over 18-months follow-up 
there was higher risk of cardiac death, MI and total 
mortality among women, in multivariate analysis 
female gender did not affect negatively the survival 
[14]. In the present study there were no signifi cant 
differences in mortality between men and women 
in general group and within STEMI/NSTEMI and 
DES/BMS subgroups.
Chieffo et al. [3] compared stenting on the 
left main bifurcation performed with two types 
of stents. In their study 45% of patients received 
DES and 34% — BMS. Serious complications 
developed in 15.8% of DES patients vs. 45.4% 
of BMS patients. Cardiac deaths were also more 
frequent in BMS patients (22.7%) than in DES 
patients (5.2%). In the present study there was 
a tendency towards lower mortality in patients with 
DES. Nevertheless the small sample size does not 
permit defi nitive conclusions or extrapolation to 
the general population.
Multivariate analysis provided extremely inte-
resting results in an attempt to answer a question 
which factors have the most important effect on 
in-hospital and long-term mortality. Of all factors 
age and symptoms of acute left ventricular failure 
were the most important predictors of mortality. 
Cardiogenic shock is a real killer and treatment of 
this dangerous complication should be instituted 
in the fi rst place in MI even if it is caused by oc-
clusion of the ULMCA. Undoubtedly treating the 
underlying cause is important. Rapid restoration 
of coronary blood fl ow also at the microcirculatory 
level is the best treatment strategy. In the pre-
sent study TIMI grade 3 fl ow resulted in a 5-fold 
decrease of annual mortality. Increasing evidence 
suggests that both treatment modalities (CABG 
and PCI) may be accepted as equivalent or comple-
mentary in patients with critical lesions in the left 
main coronary artery, because once a patient with 
MI has stabilized and the acute phase has passed, 
complete revascularization with CABG after PCI 
of the left main is still possible.
Limitations of the study
Despite our study presents important data, 
it has several limitations. First, its retrospective 
nature biases the conclusions. Second, the choice of 
treatment strategy was operator dependent. Third, 
small number of DES used resulted in insignifi cant 
differences in outcomes what is known to be false. 
Finally, we have no data on lesion location (ostial 
vs. bifurcation of the ULMCA) and manual throm-
bectomy prior to PCI which also have signifi cant 
impact on mortality.
Conclusions
No signifi cant differences in clinical course, 
treatment and prognosis between men and women 
were noted, although women were older and had 
more concomitant risk factors. Mortality remained 
very high in both genders. The most unfavorable 
prognostic factors were cardiogenic shock, pulmo-
nary edema, STEMI and advanced age. Percutane-
ous coronary angioplasty is feasible and offers high 
success rate in this subset of patients.
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